© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Name: Lenalidomide Chemical Formula: C13H13N3O3 Common Use: Treatment of multiple myeloma and myelodysplastic syndromes Form: White to pale-yellow powder Routes of Exposure: Inhalation, ingestion, skin absorption, eye contact Relevant Populations: Healthcare workers, pharmaceutical handlers, patients
Acute Health Hazards: Causes eye and skin irritation; may cause reversible or irreversible harm on prolonged contact Chronic Health Hazards: Increased risk of birth defects, possible fetal toxicity; carried teratogenic and embryotoxic warnings Carcinogenicity: No current evidence suggests known carcinogenicity Routes Most Concerned: Inhalation and ingestion by workers in research or pharmacy settings; accidental skin exposure poses distinct reproductive hazards Signal Word: Danger for pregnant women, caution in all user scenarios
Main Ingredient: Lenalidomide, purity typically greater than 99% in clinical formulations Other Ingredients: Typically excipients in tablets, but the concern remains with the active itself CAS Number: 191732-72-6
Eye Contact: Rinse immediately with water, remove contact lenses if possible, flush thoroughly for several minutes Skin Contact: Remove contaminated clothing, wash area with soap and water, seek medical help if irritation develops Inhalation: Move to fresh air, seek medical attention if symptoms arise Ingestion: Rinse mouth, do not induce vomiting, obtain medical advice Clinical Response: Clear communication about reproductive risk is critical, especially for women of childbearing potential
Suitable Extinguishing Media: Dry chemical, foam, carbon dioxide; water spray as a cooling agent Specific Hazards: Emits hazardous fumes under fire, including oxides of carbon and nitrogen Protective Equipment: Self-contained breathing apparatus, chemical splash suit, and gloves Special Notes: Fire residue and contaminated water need controlled disposal because of persistence and toxicity
Personal Precautions: Wear gloves, respiratory protection, and safety glasses; avoid generating dust Environmental Precautions: Prevent product from entering water systems and drains Methods for Cleaning: Moisten to reduce dust, scoop up carefully, clean area with mild detergent, dispose in sealed container Reporting: Immediate reporting to safety officials in healthcare and laboratory settings is crucial to prevent secondary exposure
Safe Handling Guidelines: Handle in designated areas, avoid unnecessary exposure, especially for pregnant or at-risk workers Storage Conditions: Store in a dry, well-ventilated spot, away from incompatible substances; must be kept secure for controlled substances Specific Concerns: Product labeling stresses the teratogenic effects, so storage protocols must include restricted access and stringent labeling
Engineering Controls: Use local exhaust ventilation; isolators or containment systems for bulk handling PPE Requirements: Gloves rated for chemical resistance, eye protection, lab coat or gown, respiratory protection in powder handling Environmental Controls: Prevent dispersion in the workplace; surface wipes to assess contamination after use
Appearance: White to pale-yellow powder Odor: No distinctive odor Melting Point: 270–274°C Solubility: Slightly soluble in water, more soluble in organic solvents such as DMSO and ethanol Stability Under Normal Conditions: Stable if kept dry and away from excessive light, heat, and oxidizing agents
Chemical Stability: Stable under recommended storage conditions Reactivity Profile: Avoid contact with strong oxidizers; decomposition may release hazardous gases under fire or extreme heat Special Decomposition Products: Nitrogen oxides, carbon monoxide, and carbon dioxide may release in a fire
Acute Toxicity: Studies indicate low oral LD50 in animal models, but precise values remain limited for humans Possible Effects: Headache, nausea, dizziness, dermatological reactions; reproductive toxicity is the greatest risk, with clear potential for harm to developing fetuses Chronic Exposure Risks: Animals demonstrated teratogenic effects: high vigilance required for those who may become pregnant Routes of Absorption: Skin, mucous membranes, inhalation, ingestion
Persistence and Degradability: Data are limited, but as with many pharmaceutical compounds, persistence in aquatic environments occurs Potential Bioaccumulation: Unknown, but as a synthetic molecule, can pose long-term threats if introduced to water systems Aquatic Toxicity: Effects on aquatic species not fully detailed, though any cytotoxic, mutagenic, or teratogenic products should be considered environmental hazards Precautionary Principle: Do not release substantial quantities to the environment; dispose of using strictly controlled protocols
Waste Management: Treat as hazardous pharmaceutical waste; incinerate through properly permitted facility Container Handling: Triple-rinsed or otherwise decontaminated before disposal; label all waste with reproductive hazard warnings Regulatory Implications: Follow local, national, and international pharmaceutical waste rules
Shipping Status: Not classified as dangerous for transport under standard guidelines but needs secure packaging due to its toxicity Transport Precautions: Ensure containers remain closed and upright; clear reproductive toxicity labeling on parcels Emergency Action: In the event of a spill, protocols for hazardous drugs during handling and transport should apply, including use of spill kits
Legal Status: Highly regulated as a controlled substance due to teratogenicity and toxicity concerns Workplace Safety Laws: Occupational exposures governed by pharmaceutical handling regulations, including OSHA guidelines in the US Medical Supervisory Protocol: Routine training and documentation for anyone involved in production, dispensing, use, or disposal Patient Safety: This drug can only be dispensed under a risk evaluation and mitigation strategy focused on pregnancy prevention
